Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
The messenger RNA (mRNA) vaccines for COVID-19, Pfizer-BioNTech and Moderna, were authorized in the US on an emergency basis in December of 2020. The rapid distribution of these therapeutics around the country and the world led to millions of people being vaccinated in a short time span, an action t...
Main Authors: | Adonis Sfera, Sabine Hazan, Jonathan J. Anton, Dan O. Sfera, Christina V. Andronescu, Sarvin Sasannia, Leah Rahman, Zisis Kozlakidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.995481/full |
Similar Items
-
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
by: Adonis Sfera, et al.
Published: (2023-10-01) -
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
by: Adonis Sfera, et al.
Published: (2022-06-01) -
Microbial Translocation Disorders: Assigning an Etiology to Idiopathic Illnesses
by: Adonis Sfera, et al.
Published: (2023-01-01) -
Long COVID as a Tauopathy: Of “Brain Fog” and “Fusogen Storms”
by: Adonis Sfera, et al.
Published: (2023-08-01) -
The Role of Lactylation in Mental Illness: Emphasis on Microglia
by: Adonis Sfera, et al.
Published: (2023-05-01)